Insider · CIK 0001786198
William Strohl
Files at IGMS (IGM Biosciences, Inc.). First filing -, latest -.
In brief
William Strohl files SEC Form 4 as director at IGMS (IGM Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; William Strohl has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | IGMS IGM Biosciences, Inc. | DDisposition to issuer Common Stock | -125,000 | - | - | 0 | Aug 14, 2025 |
Questions about William Strohl
Answered from the filings on this page, as of the latest one.
Is William Strohl buying or selling?
William Strohl has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did William Strohl's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William Strohl has 0.
Where does William Strohl file Form 4?
William Strohl has filed Form 4 at IGMS (IGM Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.